Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-24-002284

Options or other derivatives

  • Chief Executive Officer acquired 166,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Climaco John M · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-04-08 Grant or award : show line 1 in the form Option to purchase common stock +83,000 476,533 D
2024-04-08 Grant or award : show line 2 in the form Restricted Stock Units +83,000 559,533 D
Loading xslF345X05/ownership.xml…